Patients with alcoholism, anxiety and the GG genotype may have decreased concentrations of alprazolam as compared to patients with the AG genotype. This annotation over covers the pharmacokinetic relationship between rs35599367 and alprazolam and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect concentrations of alprazolam in a patient.